Ground News

News from Intelligence360 News

Stay current with all the latest and breaking news from Intelligence360 News. Compare headlines and media bias behind news outlets on stories breaking today.

Overall, we’ve indexed 948 stories from Intelligence360 News over the past 3 months.

Ground News rates Intelligence360 News’s media bias as unknown. . Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check.

If you want to know if Intelligence360 News is credible or reliable, look no further. We rank Intelligence360 News as Unknown factuality. Find out more about our methodology here.

Information about Intelligence360 News

Where is Intelligence360 News located?Intelligence360 News's Website

Media Bias Ratings

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Intelligence360 News News

Donald Trump · Austin

Texas Legislature Approves $8.5 Billion Boost for Public Schools After Years of Stagnant Funding

64% Center coverage: 17 sources

The Texas House on Thursday gave the final stamp of approval to legislation authorizing roughly $8.5 billion in funding for public schools, sending the bill to Gov. Greg Abbott’s desk where it is soon expected to become law.See the Story

Artificial Intelligence

Siro Raises $50M Series B to Bring AI to In-Person Sales

100% Center coverage: 15 sources

Led by SignalFire, the round fuels growth of AI-powered conversation intelligence platform built for face-to-face sellers See the Story

Stock Markets

AbbVie To Present Cancer Trial Data At Upcoming ASCO Event - AbbVie (NYSE:ABBV)

100% Center coverage: 3 sources

AbbVie Inc (NYSE:ABBV) stock is trending on Tuesday after the U.S. drug giant announced that key data from its broad oncology portfolio will be showcased at the upcoming American Society of Clinical Oncology (ASCO) Annual Meeting. An oral presentation on investigational elotuzumab adizutecan (ABBV-400, Temab-A), a next-generation, c-Met directed antibody-drug conjugate (ADC) with a novel topoisomerase 1 inhibitor (Top1i) payload, will showcase: …See the Story

News from Intelligence360 News